Literature DB >> 18216225

Alterations of GABA A-receptor function and allosteric modulation during development of status epilepticus.

Hua-Jun Feng1, Gregory C Mathews, Chris Kao, Robert L Macdonald.   

Abstract

Partial limbic seizures in rodents induced by pilocarpine progress from stages I-II (mouth and facial movements; head nodding) to stage III (forelimb clonus) and then progress rapidly to stages IV-V (generalized limbic seizures; rearing, and rearing with falling) followed by status epilepticus (SE). Although limbic seizures in rodents are terminated by benzodiazepines, a group of gamma-aminobutyric acid type A (GABA(A))-receptor positive modulators, significant pharmacoresistance to benzodiazepines develops within minutes during SE. The alterations of GABA(A)-receptor function and allosteric modulation during development of SE are poorly understood. We induced seizures in juvenile rats by administration of lithium followed by pilocarpine, and whole cell recordings of miniature inhibitory postsynaptic currents (mIPSCs) were obtained from hippocampal dentate granule cells in brain slices. Compared with a sham-treated group, mIPSC amplitude was reduced and decay was accelerated at onset of the first occurrence of stage III (S3) seizures [S3(0)], resulting in a reduction in the total charge transfer at S3(0). Recovery of mIPSC amplitude and prolongation of mIPSC decay occurred 30 min after onset of S3 seizures [S3(30)]. The mIPSC frequency was not altered for S3(0) and S3(30) neurons compared with sham neurons. The net enhancement of total charge transfer by diazepam was smaller for S3(30) than that for sham and S3(0) neurons; however, the net reduction of total charge transfer by zinc was greater for S3(30) than that for sham and S3(0) neurons. These findings suggest that substantial plastic changes of GABA(A)-receptor function and allosteric modulation occur rapidly in neurons from juvenile animals during development of SE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216225     DOI: 10.1152/jn.01180.2007

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  14 in total

Review 1.  Altered GABA(A) receptor expression during epileptogenesis.

Authors:  Marco I González; Amy Brooks-Kayal
Journal:  Neurosci Lett       Date:  2011-03-03       Impact factor: 3.046

2.  Inhibiting with-no-lysine kinases enhances K+/Cl- cotransporter 2 activity and limits status epilepticus.

Authors:  Kathryn L Lee; Krithika Abiraman; Christopher Lucaj; Thomas A Ollerhead; Nicholas J Brandon; Tarek Z Deeb; Jamie Maguire; Stephen J Moss
Journal:  Brain       Date:  2022-04-29       Impact factor: 15.255

3.  Benzodiazepine administration patterns before escalation to second-line medications in pediatric refractory convulsive status epilepticus.

Authors:  Theodore Sheehan; Marta Amengual-Gual; Alejandra Vasquez; Nicholas S Abend; Anne Anderson; Brian Appavu; Ravindra Arya; Cristina Barcia Aguilar; J Nicholas Brenton; Jessica L Carpenter; Kevin E Chapman; Justice Clark; Raquel Farias-Moeller; William D Gaillard; Marina Gaínza-Lein; Tracy A Glauser; Joshua L Goldstein; Howard P Goodkin; Réjean M Guerriero; Linda Huh; Michele Jackson; Kush Kapur; Robert Kahoud; Yi-Chen Lai; Tiffani L McDonough; Mohamad A Mikati; Lindsey A Morgan; Edward J Novotny; Adam P Ostendorf; Eric T Payne; Katrina Peariso; Juan Piantino; Latania Reece; James J Riviello; Tristan T Sands; Kumar Sannagowdara; Renee Shellhaas; Garnett Smith; Robert C Tasker; Dmitry Tchapyjnikov; Alexis A Topjian; Mark S Wainwright; Angus Wilfong; Korwyn Williams; Bo Zhang; Tobias Loddenkemper
Journal:  Epilepsia       Date:  2021-08-21       Impact factor: 6.740

Review 4.  Why won't it stop? The dynamics of benzodiazepine resistance in status epilepticus.

Authors:  Richard J Burman; Richard E Rosch; Jo M Wilmshurst; Arjune Sen; Georgia Ramantani; Colin J Akerman; Joseph V Raimondo
Journal:  Nat Rev Neurol       Date:  2022-05-10       Impact factor: 44.711

Review 5.  Molecular pathways controlling inhibitory receptor expression.

Authors:  Heidi L Grabenstatter; Shelley J Russek; Amy R Brooks-Kayal
Journal:  Epilepsia       Date:  2012-12       Impact factor: 5.864

Review 6.  Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures.

Authors:  Tarek Z Deeb; Jamie Maguire; Stephen J Moss
Journal:  Epilepsia       Date:  2012-12       Impact factor: 5.864

Review 7.  Molecular mechanisms of antiseizure drug activity at GABAA receptors.

Authors:  L John Greenfield
Journal:  Seizure       Date:  2013-05-14       Impact factor: 3.184

Review 8.  NMDA antagonists for refractory seizures.

Authors:  F A Zeiler; J Teitelbaum; L M Gillman; M West
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

9.  Diazepam administration after prolonged status epilepticus reduces neurodegeneration in the amygdala but not in the hippocampus during epileptogenesis.

Authors:  Felicia Qashu; Taiza H Figueiredo; Vassiliki Aroniadou-Anderjaska; James P Apland; Maria F M Braga
Journal:  Amino Acids       Date:  2009-01-07       Impact factor: 3.520

10.  CK1δ over-expressing mice display ADHD-like behaviors, frontostriatal neuronal abnormalities and altered expressions of ADHD-candidate genes.

Authors:  Mingming Zhou; Jodi Gresack; Jia Cheng; Kunihiro Uryu; Lars Brichta; Paul Greengard; Marc Flajolet
Journal:  Mol Psychiatry       Date:  2018-10-19       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.